Inovio Pharmaceuticals (INO) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Inovio Pharmaceuticals (INO) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Inovio Pharmaceuticals

· INO

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

114.771 M

+9.91%

General

Market Cap: $114.77M
Enterprise Value: $60.77M
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -136.52%
ROE: -1005.80%
ROIC: -640.60%
Current Ratio: 1.00
Debt-to-Equity: 1.83
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 19.28
EV/EBITDA: -0.94

Growth

Rev 1Y: -69.99%
Rev 1Y Fwd Est: 920.26%
Rev 3Y (CAGR): -81.47%
Rev 5Y (CAGR): -61.18%
Rev 10Y (CAGR): -47.43%
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $77.76M
Operating Income: -$79.26M
Net Profit: -$67.43M

Balance Sheet

Cash and Equivalents: $31.53M
Working Capital: -$1.81K
Total Assets: $49.39M
Net Debt: -$23.52M
Total Liabilities: $45.02M
Total Equity: $4.37M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$80.58M
Cash Flow from Investing: $17.59M
Cash Flow from Financing: $70.17M
Free Cash Flow: -$80.78M
Capital Expenditures: $195.4K